Trials / Completed
CompletedNCT02054247
Continuous And Pulsed Ultrasound Treatments On Carpal Tunnel Syndrome
The Placebo-Controlled Continuous And Pulsed Ultrasound Treatments on Carpal Tunnel Syndrome : A Randomised Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Eskisehir Osmangazi University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of this placebo-controlled study was to evaluate the effects of pulsed and continuous ultrasound treatments combined with splint therapy on patients with mild and moderate idiopathic carpal tunnel syndrome
Detailed description
The study included 36 carpal tunnel syndrome patients who were randomly divided into 3 groups.The first group received 0 W/cm2 placebo ultrasound treatment. second group received 1.0 W/cm2 continuous ultrasound treatment and the third group received 1.0 W/cm2 1:4 pulsed ultrasound treatment 5 days a week for a total of 15 sessions. All patients were also treated with night splints during the treatment. Pretreatment and posttreatment Visual Analogue Scale scores, Symptom Severity Scale scores, Functional Status Scale scores, median nerve motor conduction velocity. and distal latency and sensory conduction velocity of median nerve in the 2nd finger and palm were compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ultrasound | a frequency of 1 megahertz and with an intensity of 1 W/cm2, 5 days a week for a total of 15 sessions |
| DEVICE | pulsed ultrasound | a frequency of 1 megahertz and with an intensity of 1 W/cm2 and a pulsed mode duty cycle of 1:4, 5 days a week for a total of 15 sessions |
| DEVICE | placebo ultrasound | same ultrasound device as described above seemed to be working but without delivering any output, 5 days a week for a total of 15 sessions |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2014-02-04
- Last updated
- 2023-11-07
- Results posted
- 2023-11-07
Source: ClinicalTrials.gov record NCT02054247. Inclusion in this directory is not an endorsement.